Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.660
-0.070 (-4.05%)
At close: Nov 26, 2025, 4:00 PM EST
1.603
-0.057 (-3.43%)
After-hours: Nov 26, 2025, 6:17 PM EST
Artelo Biosciences Employees
Artelo Biosciences had 6 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,081,833
Market Cap
3.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | 0 | - |
| Dec 31, 2023 | 6 | -1 | -14.29% |
| Dec 31, 2022 | 7 | 2 | 40.00% |
| Dec 31, 2021 | 5 | 0 | - |
| Aug 31, 2021 | 5 | 2 | 66.67% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ARTL News
- 15 days ago - Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 23 days ago - Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer - GlobeNewsWire
- 4 weeks ago - Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer - GlobeNewsWire
- 6 weeks ago - Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit - GlobeNewsWire
- 2 months ago - Artelo Biosciences Announces Closing of $2.0 Million Public Offering - GlobeNewsWire
- 2 months ago - Artelo Biosciences Announces Pricing of $2.0 Million Public Offering - GlobeNewsWire
- 2 months ago - Artelo Biosciences Announces Proposed Underwritten Public Offering - GlobeNewsWire
- 2 months ago - Artelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference - GlobeNewsWire